ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Arizona » Ophthalmology

Top Ophthalmology Prescribers in Arizona

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ANDREW RABINOWITZ MD

Ophthalmology

7,621

$501K

1204
1094 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

46%
prescriptions for brand name drugs

Avg: 61%

$66
Average prescription price

Avg: $73

JOHN LEWIS M.D.

Ophthalmology

5,972

$504K

1112
983 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

71%
prescriptions for brand name drugs

Avg: 61%

$84
Average prescription price

Avg: $73

NEIL ATODARIA MD

Ophthalmology

5,588

$389K

985
899 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

60%
prescriptions for brand name drugs

Avg: 61%

$70
Average prescription price

Avg: $73

GEORGE REISS M.D.

Ophthalmology

5,428

$497K

966
885 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

68%
prescriptions for brand name drugs

Avg: 61%

$92
Average prescription price

Avg: $73

HARMOHINA BAGGA M.D.

Ophthalmology

5,159

$355K

1032
979 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

66%
prescriptions for brand name drugs

Avg: 61%

$69
Average prescription price

Avg: $73

SCOTT PERKINS MD

Ophthalmology

4,585

$332K

1274
1200 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

96%
prescriptions for brand name drugs

Avg: 61%

$72
Average prescription price

Avg: $73

JASON LEVINE MD

Ophthalmology

4,318

$266K

828
701 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

61%
prescriptions for brand name drugs

Avg: 61%

$62
Average prescription price

Avg: $73

JEFFREY KAY MD

Ophthalmology

4,014

$318K

688
636 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

72%
prescriptions for brand name drugs

Avg: 61%

$79
Average prescription price

Avg: $73

LAURENCE KAYE MD

Ophthalmology

3,948

$318K

846
805 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

68%
prescriptions for brand name drugs

Avg: 61%

$80
Average prescription price

Avg: $73

PATRICK AIELLO MD

Ophthalmology

3,786

$177K

950
876 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

43%
prescriptions for brand name drugs

Avg: 61%

$47
Average prescription price

Avg: $73

KENNETH SNOW DO

Ophthalmology

3,703

$292K

830
740 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

83%
prescriptions for brand name drugs

Avg: 61%

$79
Average prescription price

Avg: $73

RAYMOND ZIMMERMAN M.D.

Ophthalmology

3,679

$390K

581
530 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

79%
prescriptions for brand name drugs

Avg: 61%

$106
Average prescription price

Avg: $73

BRIAN CHANG M.D.

Ophthalmology

3,648

$248K

869
793 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

58%
prescriptions for brand name drugs

Avg: 61%

$68
Average prescription price

Avg: $73

SCOTT GLESMANN MD

Ophthalmology

3,338

$152K

686
600 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

42%
prescriptions for brand name drugs

Avg: 61%

$46
Average prescription price

Avg: $73

JEFFREY MALTZMAN M.D.

Ophthalmology

3,198

$424K

678
645 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

77%
prescriptions for brand name drugs

Avg: 61%

$132
Average prescription price

Avg: $73

KENNETH BATKO MD

Ophthalmology

3,149

$206K

584
560 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

52%
prescriptions for brand name drugs

Avg: 61%

$65
Average prescription price

Avg: $73

ROBERT MCCULLOCH MD

Ophthalmology

2,994

$169K

763
719 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

23%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

70%
prescriptions for brand name drugs

Avg: 61%

$56
Average prescription price

Avg: $73

DANIEL SCHICKNER MD

Ophthalmology

2,794

$168K

602
527 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

52%
prescriptions for brand name drugs

Avg: 61%

$60
Average prescription price

Avg: $73

SHAMIL PATEL MD, MBA

Ophthalmology

2,782

$203K

611
502 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

65%
prescriptions for brand name drugs

Avg: 61%

$73
Average prescription price

Avg: $73

CURTIS WINKLER MD

Ophthalmology

2,766

$256K

841
810 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

79%
prescriptions for brand name drugs

Avg: 61%

$93
Average prescription price

Avg: $73

JAMES TAMMARO MD

Ophthalmology

2,763

$323K

837
785 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

89%
prescriptions for brand name drugs

Avg: 61%

$117
Average prescription price

Avg: $73

BARTON HODES MD

Ophthalmology

2,615

$148K

465
443 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

47%
prescriptions for brand name drugs

Avg: 61%

$57
Average prescription price

Avg: $73

MICHAEL HORSLEY M.D.

Ophthalmology

2,594

$196K

613
539 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

72%
prescriptions for brand name drugs

Avg: 61%

$76
Average prescription price

Avg: $73

ROBERT FINTELMANN MD

Ophthalmology

2,577

$153K

697
639 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

75%
prescriptions for brand name drugs

Avg: 61%

$59
Average prescription price

Avg: $73

CRAIG SUITER MD

Ophthalmology

2,500

$227K

549
483 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

77%
prescriptions for brand name drugs

Avg: 61%

$91
Average prescription price

Avg: $73

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank